Approved Therapy

Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates

Arch Ophthalmol. 2011 Aug;129(8):1042-52. doi: 10.1001/archophthalmol.2011.210.

ABSTRACT

OBJECTIVE: To evaluate the efficacy of systemic and intravitreous administration of VEGF Trap (aflibercept) in a nonhuman primate model of choroidal neovascularization (CNV).